Dr He on the Evaluation of Camrelizumab Plus Rivoceranib in Unresectable HCC
Aiwu Ruth He, MD, PhD, discusses the evaluation of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma.
Source: onclive.com
Biliary Cancers News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biliary Cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biliary Cancers Today - Breaking & Trending Today